As a potent effector of innate immunity, the
complement system has been shown to be involved in the pathogenesis of
inflammatory bowel disease (IBD). However, the role of the
membrane attack complex (MAC) in the development of IBD is still largely unknown. Here, we used C6-deficient mice in which MAC formation was blocked due to the absence of C6 to develop an acute
colitis model by the administration of
dextran sulfate sodium (DSS). The results showed that DSS-induced
colitis was aggravated in C6-deficient mice compared with wild-type (WT) mice, as represented by the markedly greater
weight loss, higher disease activity index (DAI), shortened colon length, more severe histological injury with increased epithelial ulcerations, and massively increased infiltration of leukocytes accompanied by much higher
myeloperoxidase (MPO) levels in local inflammatory colonic sites. In addition, the DSS-induced
colitis in C6-deficient mice could be significantly ameliorated by the exogenous C6 from WT sera. Furthermore, the significantly enhanced production of pro-inflammatory mediators, including IL-1β,
IL-6, CXCL-1, CCL-3, TGF-β1 and
IL-17F, was also observed in C6-deficient mice. Unexpectedly, the aggravated
colitis in C6-deficient mice may be not due to the increase of
lipopolysaccharide (LPS) levels in serum. Overall, we demonstrated that MAC exerts a protective role in acute
colitis, strongly highlighting the host defense function of the
complement system.